Accessibility Menu

Geron(FRA) GON

Market Cap€831.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€1.29
-0.54%
-0.01Today

Geron Financials at a Glance

Market Cap

€831.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€175.41

Net Income (TTM)

-€59.99

EPS (TTM)

-€0.09

P/E Ratio

-14.42

Dividend

€0.00

Beta (Volatility)

0.12 (Low)

Price

€1.29

Volume

0

Open

€1.29

Previous Close

€1.29

Daily Range

€1.29 - €1.29

52-Week Range

€0.92 - €1.63

Estimated Earnings Date

N/A

GON News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Geron

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Industry

Biotechnology

Employees

258

CEO

Harout Semerjian, MBA

GON Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-29.10%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-6.93%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€831.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

642.47M

Volume

0

Avg. Volume

1.30K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Geron Performance Analysis

Geron annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 567,093-51.9%
20232023-12-31EUR 219,218-61.3%
20242024-12-31EUR 71,179,30832369.6%
20252025-12-31EUR 162,931,590128.9%
Geron annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -0.3518.3%
20232023-12-31EUR -0.30-15.8%
20242024-12-31EUR -0.25-16.3%
20252025-12-31EUR -0.11-55.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€49.44

+1.1%

Gross Profit

€46.93

+1.1%

Gross Margin

94.94%

+1.0%

Market Cap

€831.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

258

N/A

Net Income

-€14.35

+1.0%

EBITDA

-€10.60

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€276.66

-1.4%

Total Debt

€220.21

+1.0%

Accounts Receivable

€45.17

+1.4%

Inventory

€108.11

+1.8%

Long Term Debt

€201.23

+1.0%

Short Term Debt

€18.98

+1.2%

Return on Assets

-12.94%

+0.7%

Return on Invested Capital

N/A

N/A

Free Cash Flow

-€14.14

+0.3%

Operating Cash Flow

-€13.95

+0.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About GON

What is the current price of Geron?

Geron is trading at €1.29 per share.

What is the 52-week range for Geron?

Over the past 52 weeks, Geron has traded between €0.92 and €1.63.

How much debt does Geron have?

As of the most recent reporting period, Geron reported total debt of €220.21M.

How much cash does Geron have on hand?

Geron reported €56.44M in cash and cash equivalents in its most recent financial results.

What is Geron’s dividend yield?

Geron does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.